{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:59:49Z","timestamp":1775152789540,"version":"3.50.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2007,4,27]],"date-time":"2007-04-27T00:00:00Z","timestamp":1177632000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.0030075","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T11:46:25Z","timestamp":1177501585000},"page":"e75","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Coping with Viral Diversity in HIV Vaccine Design"],"prefix":"10.1371","volume":"3","author":[{"given":"David C","family":"Nickle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei L. Kosakovsky","family":"Pond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Seligman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Heckerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James I","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nebojsa","family":"Jojic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2007,4,27]]},"reference":[{"issue":"Supplement 1","key":"pcbi-0030075-b001","first-page":"S151","article-title":"Immunogen sequence: The fourth tier of AIDS vaccine design.","volume":"3","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"pcbi-0030075-b002","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1586\/14760584.3.4.S161","article-title":"Centralized immunogens as a vaccine strategy to overcome HIV-1 diversity.","volume":"3","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"pcbi-0030075-b003","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.4049\/jimmunol.142.10.3612","article-title":"Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T-helper cell sites and B-cell neutralization epitopes.","volume":"142","year":"1989","journal-title":"J Immunol"},{"key":"pcbi-0030075-b004","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.vaccine.2005.01.097","article-title":"HIV vaccine development by computer assisted design: The GAIA vaccine.","volume":"23","year":"2005","journal-title":"Vaccine"},{"key":"pcbi-0030075-b005","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1016\/j.vaccine.2005.04.045","article-title":"Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use.","volume":"23","year":"2005","journal-title":"Vaccine"},{"key":"pcbi-0030075-b006","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection.","volume":"296","year":"2002","journal-title":"Science"},{"key":"pcbi-0030075-b007","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1128\/JVI.79.2.1154-1163.2005","article-title":"Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein.","volume":"79","year":"2005","journal-title":"J Virol"},{"key":"pcbi-0030075-b008","unstructured":"LearnGMullinsJI 2000 Inferring an ancestral Asian HIV-1 subtype E env sequence for use as a vaccine immunogen. In Proceedings of the Meeting of the AIDS Panels for the U.S.-Japan Cooperative Medical Science Program. 12th Joint Scientific Meeting of the U.S.-Japan Cooperative Medical Science Program 22\u201324 March 2000; Santa Fe, New Mexico, United States."},{"key":"pcbi-0030075-b009","unstructured":"LearnGMullinsJI 2000 The use of an inferred epidemic ancestral sequence as a vaccine immunogen [abstract] 7th Annual International Discussion Meeting on HIV Dynamics and Evolution; 28\u201330 April 2000; Seattle, Washington, United States. Available: http:\/\/ubik.microbiol.washington.edu\/Seattle2000\/abstracts\/abstract30.html. Accessed 28 March 2007."},{"key":"pcbi-0030075-b010","unstructured":"MullinsJIRodrigoAGLearnGHDoria-RoseNHaigwoodN 2002 How should HIV strains be chosen for inclusion in vaccines [abstract]? Keystone Symposium, HIV-1 Protection and Control by Vaccination, 5\u201311 April 2002; Keystone, Colorado, United States."},{"key":"pcbi-0030075-b011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/374012a0","article-title":"Molecular evolution. Active ancestral molecules.","volume":"374","year":"1995","journal-title":"Nature"},{"key":"pcbi-0030075-b012","doi-asserted-by":"crossref","first-page":"11214","DOI":"10.1128\/JVI.79.17.11214-11224.2005","article-title":"Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope.","volume":"79","year":"2005","journal-title":"J Virol"},{"key":"pcbi-0030075-b013","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.299.5612.1515c","article-title":"Consensus and ancestral state HIV vaccines.","volume":"299","year":"2003","journal-title":"Science"},{"key":"pcbi-0030075-b014","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.","volume":"283","year":"1999","journal-title":"Science"},{"key":"pcbi-0030075-b015","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.","volume":"189","year":"1999","journal-title":"J Exp Med"},{"key":"pcbi-0030075-b016","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.","volume":"68","year":"1994","journal-title":"J Virol"},{"key":"pcbi-0030075-b017","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary HIV-1 infection.","volume":"68","year":"1994","journal-title":"J Virol"},{"key":"pcbi-0030075-b018","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1128\/JVI.00575-06","article-title":"Selection on the human immunodeficiency virus type 1 proteome following primary infection.","volume":"80","year":"2006","journal-title":"J Virol"},{"issue":"Supplement 1","key":"pcbi-0030075-b019","first-page":"S7","article-title":"Global epidemiology of HIV.","volume":"78","year":"2006","journal-title":"J Med Virol"},{"key":"pcbi-0030075-b020","unstructured":"JojicNJojicVFreyBMeekCHeckermanD 2005 Using epitomes to model genetic diversity: Rational design of HIV vaccine cocktails. In Proceedings of Neural Information Processing Systems (NIPS) 19th Annual Conference on Neural Information Processing Systems; 5\u201310 December 2005; Whistler, British Columbia, Canada. Available: http:\/\/books.nips.cc\/papers\/files\/nips18\/NIPS2005_0759.pdf. Accessed 28 March 2007."},{"key":"pcbi-0030075-b021","doi-asserted-by":"crossref","unstructured":"JojicNFreyBKannanA 2003 Epitomic analysis of appearance and shape. In Proceedings of the Ninth IEEE International Conference on Computer Vision, Volume 2 Washington (D. C.) IEEE Computer Society 34 43","DOI":"10.1109\/ICCV.2003.1238311"},{"key":"pcbi-0030075-b022","unstructured":"LeitnerTFoleyBHahnBMarxPMcCutchanF 2006 HIV Sequence Compendium 2005 Los Alamos (New Mexico) Theoretical Biology and Biophysics Group, Los Alamos National Laboratory 648 + viii p."},{"key":"pcbi-0030075-b023","unstructured":"HillisDMMoritzCMableBK 1996 Molecular systematics 2nd edition Sunderland (Massachusetts) Sinauer Associates 655"},{"key":"pcbi-0030075-b024","unstructured":"SwoffordDL 1999 PAUP* 4.0: Phylogenetic Analysis Using Parsimony (*and Other Methods). 4.0b2a ed Sunderland (Massachusetts) Sinauer Associates"},{"key":"pcbi-0030075-b025","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.20040511","article-title":"Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.","volume":"200","year":"2004","journal-title":"J Exp Med"},{"key":"pcbi-0030075-b026","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1128\/JVI.79.21.13239-13249.2005","article-title":"Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.","volume":"79","year":"2005","journal-title":"J Virol"},{"key":"pcbi-0030075-b027","unstructured":"KorberBTMBranderCHaynesBFKoupRMooreJP 2005 HIV Molecular Immunology 2005 Los Alamos (New Mexico) Los Alamos National Laboratory, Theoretical Biology and Biophysics 1158"},{"key":"pcbi-0030075-b028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.immunol.17.1.51","article-title":"Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.","volume":"17","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"pcbi-0030075-b029","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.4049\/jimmunol.173.10.6284","article-title":"Single-epitope DNA vaccination prevents exhaustion and facilitates a broad antiviral CD8+ T cell response during chronic viral infection.","volume":"173","year":"2004","journal-title":"J Immunol"},{"key":"pcbi-0030075-b030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1074-7613(00)80161-2","article-title":"Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.","volume":"12","year":"2000","journal-title":"Immunity"},{"key":"pcbi-0030075-b031","first-page":"4510","article-title":"Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice.","volume":"24","year":"2005","journal-title":"Vaccine"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.0030075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T15:38:09Z","timestamp":1683819489000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.0030075"}},"subtitle":[],"editor":[{"given":"Sebastion","family":"Bonhoeffer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,4,27]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2007,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.0030075","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,27]]}}}